PE20050880A1 - Proceso para reducir la cantidad de 14-hidroxicodeinona en una preparacion de clorhidrato de oxicodona - Google Patents
Proceso para reducir la cantidad de 14-hidroxicodeinona en una preparacion de clorhidrato de oxicodonaInfo
- Publication number
- PE20050880A1 PE20050880A1 PE2005000361A PE2005000361A PE20050880A1 PE 20050880 A1 PE20050880 A1 PE 20050880A1 PE 2005000361 A PE2005000361 A PE 2005000361A PE 2005000361 A PE2005000361 A PE 2005000361A PE 20050880 A1 PE20050880 A1 PE 20050880A1
- Authority
- PE
- Peru
- Prior art keywords
- oxycodone
- hydroxycodeinone
- composition
- amount
- hydrochloride
- Prior art date
Links
- YYCRAERBSFHMPL-XFKAJCMBSA-N (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,7a,13-tetrahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one Chemical compound O=C([C@@H]1O2)C=C[C@@]3(O)[C@]4([H])N(C)CC[C@]13C1=C2C(OC)=CC=C1C4 YYCRAERBSFHMPL-XFKAJCMBSA-N 0.000 title abstract 5
- YYCRAERBSFHMPL-UHFFFAOYSA-N 14beta-Hydroxycodeinone Natural products O1C2C(=O)C=CC3(O)C4CC5=CC=C(OC)C1=C5C23CCN4C YYCRAERBSFHMPL-UHFFFAOYSA-N 0.000 title abstract 5
- BQNSLJQRJAJITR-UHFFFAOYSA-N 1,1,2-trichloro-1,2-difluoroethane Chemical compound FC(Cl)C(F)(Cl)Cl BQNSLJQRJAJITR-UHFFFAOYSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 229960003617 oxycodone hydrochloride Drugs 0.000 title abstract 3
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical group O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 abstract 4
- 229960002085 oxycodone Drugs 0.000 abstract 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 3
- 229960000240 hydrocodone Drugs 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 238000013375 chromatographic separation Methods 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000005984 hydrogenation reaction Methods 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
- C07D489/04—Salts; Organic complexes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55749204P | 2004-03-30 | 2004-03-30 | |
| US60153404P | 2004-08-13 | 2004-08-13 | |
| US62007204P | 2004-10-18 | 2004-10-18 | |
| US64862505P | 2005-01-31 | 2005-01-31 | |
| US65177805P | 2005-02-10 | 2005-02-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20050880A1 true PE20050880A1 (es) | 2005-11-16 |
Family
ID=35124996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005000361A PE20050880A1 (es) | 2004-03-30 | 2005-03-29 | Proceso para reducir la cantidad de 14-hidroxicodeinona en una preparacion de clorhidrato de oxicodona |
Country Status (38)
Families Citing this family (110)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| KR20120104199A (ko) * | 2003-08-06 | 2012-09-20 | 그뤼넨탈 게엠베하 | 남용 방지 제형 |
| US20070048228A1 (en) * | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
| US8075872B2 (en) | 2003-08-06 | 2011-12-13 | Gruenenthal Gmbh | Abuse-proofed dosage form |
| DE10361596A1 (de) * | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE102004020220A1 (de) * | 2004-04-22 | 2005-11-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform |
| US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
| TW201509943A (zh) | 2004-03-30 | 2015-03-16 | Euro Celtique Sa | 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝 |
| DE102004032049A1 (de) * | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| DE102004032103A1 (de) * | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| GB0421149D0 (en) * | 2004-09-23 | 2004-10-27 | Johnson Matthey Plc | Preparation of oxycodone |
| US20080152595A1 (en) * | 2004-11-24 | 2008-06-26 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| DE102005005449A1 (de) * | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE602006018208D1 (de) * | 2005-03-04 | 2010-12-23 | Euro Celtique Sa | Verfahren zur Verminderung von Alpha, Beta-ungesättigten Ketonen in Opioidzusammensetzungen |
| US20070082845A1 (en) * | 2005-07-15 | 2007-04-12 | The Penn State Research Foundation | Ferritin as a therapeutic target in abnormal cells |
| JP5415075B2 (ja) | 2005-11-22 | 2014-02-12 | コントロールド・ケミカルズ・インコーポレーテッド | オキシコドン及び他の組成物中の混入しているマイケル受容体レベルを低減させる方法 |
| US20070117826A1 (en) * | 2005-11-23 | 2007-05-24 | Forest Laboratories, Inc. | Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone |
| ATE448231T1 (de) | 2006-03-02 | 2009-11-15 | Mallinckrodt Inc | Verfahren zur herstellung von morphinan-6-on- produkten mit geringen konzentrationen von alpha-,beta-ungesättigten ketonverbindungen |
| SA07280459B1 (ar) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
| US20080125592A1 (en) * | 2006-10-17 | 2008-05-29 | Penick Corporation | Process for preparing oxymorphone, naltrexone, and buprenorphine |
| CA2674915C (en) | 2006-10-17 | 2015-06-30 | Penick Corporation | Process for preparing oxymorphone |
| WO2008048711A1 (en) * | 2006-10-17 | 2008-04-24 | Penick Corporation | Process for preparing oxymorphone |
| JP2010511726A (ja) | 2006-12-04 | 2010-04-15 | ノランコ・インコーポレーテツド | １４−ヒドロキシコデイノンの濃度が低いオキシコドンの製造方法 |
| US7875719B2 (en) | 2006-12-04 | 2011-01-25 | Cox D Phillip | Process for reducing impurities in oxycodone base |
| GB0624880D0 (en) * | 2006-12-14 | 2007-01-24 | Johnson Matthey Plc | Improved method for making analgesics |
| DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
| CA2681740A1 (en) * | 2007-03-23 | 2008-10-02 | Mallinckrodt Inc. | Improved preparation of oxymorphone from oripavine |
| EP2137190B1 (en) * | 2007-04-16 | 2013-06-12 | Mallinckrodt LLC | Novel opiate reduction utilizing catalytic hydrogen transfer reaction |
| NZ586792A (en) | 2008-01-25 | 2012-09-28 | Gruenenthal Chemie | Tamper resistant controlled release pharmaceutical tablets form having convex and concave surfaces |
| US8372432B2 (en) | 2008-03-11 | 2013-02-12 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
| AU2009223061B2 (en) * | 2008-03-11 | 2014-10-09 | Depomed Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
| TWI524904B (zh) | 2008-05-09 | 2016-03-11 | 歌林達股份有限公司 | 製備醫藥用固體劑型，尤指錠劑之方法，及製備固體劑型，尤指錠劑之前驅物之方法 |
| AU2009294308B2 (en) * | 2008-09-18 | 2013-05-30 | Purdue Pharma L.P. | Pharmaceutical dosage forms comprising poly(e-caprolactone) |
| EP2456427B1 (en) * | 2009-07-22 | 2015-03-04 | Grünenthal GmbH | Hot-melt extruded controlled release dosage form |
| RU2555531C2 (ru) * | 2009-07-22 | 2015-07-10 | Грюненталь Гмбх | Защищенная от применения не по назначению лекарственная форма для чувствительных к окислению опиоидов |
| BR112012004525A2 (pt) * | 2009-08-31 | 2016-03-22 | Depomed Inc | composição farmacêuticas gástrico-rententivas para liberação imediata ou prolongada de acetaminofeno |
| ES2569925T3 (es) | 2009-09-30 | 2016-05-13 | Acura Pharmaceuticals, Inc. | Métodos y composiciones de disuasión del abuso |
| US9198861B2 (en) | 2009-12-22 | 2015-12-01 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
| US8597681B2 (en) | 2009-12-22 | 2013-12-03 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
| EP2531176B1 (en) * | 2010-02-03 | 2016-09-07 | Grünenthal GmbH | Preparation of a powdery pharmaceutical composition by means of an extruder |
| EP2377866B1 (en) | 2010-03-23 | 2014-02-26 | Siegfried AG | Preparation of low impurity opiates in a continuous flow reactor |
| CA2798884C (en) | 2010-05-10 | 2016-09-13 | Euro-Celtique S.A. | Manufacturing of active-free granules and tablets comprising the same |
| WO2011141490A1 (en) | 2010-05-10 | 2011-11-17 | Euro-Celtique S.A. | Combination of active loaded granules with additional actives |
| TWI483748B (zh) | 2010-05-10 | 2015-05-11 | Euro Celtique Sa | 含有氫嗎啡酮（ｈｙｄｒｏｍｏｒｐｈｏｎｅ）和納洛酮（ｎａｌｏｘｏｎｅ）之藥學組成物 |
| TWI471289B (zh) | 2010-06-11 | 2015-02-01 | Rhodes Technologies | 使三級胺進行ｎ－脫烷反應之方法 |
| CA2802295C (en) | 2010-06-11 | 2016-09-20 | Rhodes Technologies | Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof |
| GB2495062A (en) | 2010-07-02 | 2013-03-27 | Johnson Matthey Plc | Process for the synthesis and purification of oxycodone |
| US8912781B2 (en) * | 2010-07-30 | 2014-12-16 | Cirrus Logic, Inc. | Integrated circuit switching power supply controller with selectable buck mode operation |
| NZ608865A (en) | 2010-09-02 | 2015-03-27 | Gruenenthal Chemie | Tamper resistant dosage form comprising an anionic polymer |
| PE20131102A1 (es) | 2010-09-02 | 2013-10-12 | Gruenenthal Chemie | Forma de dosificacion resistente a manipulacion que comprende una sal inorganica |
| US8741885B1 (en) | 2011-05-17 | 2014-06-03 | Mallinckrodt Llc | Gastric retentive extended release pharmaceutical compositions |
| US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
| US9050335B1 (en) | 2011-05-17 | 2015-06-09 | Mallinckrodt Llc | Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia |
| NO2736495T3 (cg-RX-API-DMAC7.html) | 2011-07-29 | 2018-01-20 | ||
| CN103857386A (zh) | 2011-07-29 | 2014-06-11 | 格吕伦塔尔有限公司 | 提供药物立即释放的抗破碎片剂 |
| ES2842453T3 (es) * | 2011-09-05 | 2021-07-14 | Siegfried Ltd | Kit que comprende un material de envasado y un producto farmacéutico o nutracéutico sólido contenido en el material de envasado |
| AU2012310251B2 (en) | 2011-09-16 | 2016-01-21 | Purdue Pharma L.P. | Tamper resistant immediate release formulations |
| JP6110384B2 (ja) | 2011-09-16 | 2017-04-05 | パーデュー ファーマ エルピー | 不正改変抵抗性医薬製剤 |
| CN104010630A (zh) | 2011-12-09 | 2014-08-27 | 普渡制药公司 | 包含聚(ε-己内酯)和聚氧乙烯的药物剂型 |
| BR112014019988A8 (pt) | 2012-02-28 | 2017-07-11 | Gruenenthal Gmbh | Forma de dosagem resistente a socamento compreendendo um composto farmacologicamente ativo e um polímero aniônico |
| TWI614037B (zh) | 2012-03-02 | 2018-02-11 | 羅德製藥公司 | 抗破壞性立即釋出型調製劑類 |
| CH708257B1 (de) | 2012-04-17 | 2019-05-15 | Purdue Pharma Lp | Zusammensetzung zur Behandlung einer Opioid-induzierten unerwünschten pharmakodynamischen Reaktion. |
| AR090695A1 (es) | 2012-04-18 | 2014-12-03 | Gruenenthal Gmbh | Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis |
| US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
| CA2877774C (en) | 2012-07-12 | 2017-07-18 | Mallinckrodt Llc | Extended release, abuse deterrent pharmaceutical compositions |
| CN104470928B (zh) * | 2012-07-16 | 2017-08-11 | 罗德科技公司 | 用于改进的阿片样物质合成的方法 |
| TW201639855A (zh) | 2012-07-16 | 2016-11-16 | 羅德科技公司 | 改良之類鴉片合成方法 |
| RU2639877C2 (ru) | 2012-08-03 | 2017-12-25 | Джонсон Мэтти Паблик Лимитед Компани | Способ получения оксикодона |
| WO2014085599A1 (en) | 2012-11-30 | 2014-06-05 | Acura Pharmaceuticals, Inc. | Self-regulated release of active pharmaceutical ingredient |
| JP6208261B2 (ja) | 2013-02-05 | 2017-10-04 | パーデュー、ファーマ、リミテッド、パートナーシップＰｕｒｄｕｅ Ｐｈａｒｍａ Ｌ．Ｐ． | タンパリング抵抗性医薬製剤 |
| WO2014130714A1 (en) * | 2013-02-20 | 2014-08-28 | University Of Washington Through Its Center For Commercialization | Hydrogenation and disproportionation catalysis |
| US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
| AR096439A1 (es) | 2013-05-29 | 2015-12-30 | Gruenenthal Gmbh | Forma de dosificación resistente al uso indebido que contiene una o más partículas |
| WO2014191397A1 (en) | 2013-05-29 | 2014-12-04 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
| CA2917136C (en) | 2013-07-12 | 2022-05-31 | Grunenthal Gmbh | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
| GB201313211D0 (en) | 2013-07-24 | 2013-09-04 | Cambrex Karlskoga Ab | New process |
| GB201313915D0 (en) * | 2013-08-02 | 2013-09-18 | Johnson Matthey Plc | Process |
| CN110172063A (zh) | 2013-08-02 | 2019-08-27 | 庄信万丰股份有限公司 | 用于制备氢羟吗啡酮的方法 |
| US9193737B2 (en) | 2013-11-07 | 2015-11-24 | Mallinckrodt Llc | Production of 6-hydroxy morphinans without the isolation of intermediates |
| BR112016009749A8 (pt) | 2013-11-13 | 2018-01-30 | Euro Celtique Sa | hidromorfona e naloxona para tratamento de dor e síndrome de disfunção intestinal opioide |
| JP6480936B2 (ja) | 2013-11-26 | 2019-03-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | クライオミリングによる粉末状医薬組成物の調製 |
| US8846923B1 (en) | 2013-12-18 | 2014-09-30 | Cody Laboratories, Inc. | Preparation of 14-hydroxycodeinone sulfate |
| US9062062B1 (en) | 2013-12-18 | 2015-06-23 | Cody Laboratories, Inc. | Synthesis of oxycodone hydrochloride |
| US10227354B2 (en) | 2013-12-18 | 2019-03-12 | Cody Laboratories, Inc. | Conversion of oxycodone base to oxycodone hydrochloride |
| EP3094634A1 (en) | 2014-01-15 | 2016-11-23 | Rhodes Technologies | Process for improved oxycodone synthesis |
| ES2672795T3 (es) | 2014-01-15 | 2018-06-18 | Rhodes Technologies | Proceso para la síntesis mejorada de oximorfona |
| WO2015120201A1 (en) | 2014-02-05 | 2015-08-13 | Kashiv Pharma, Llc | Abuse-resistant drug formulations with built-in overdose protection |
| CA2943728C (en) | 2014-03-26 | 2020-03-24 | Sun Pharma Advanced Research Company Ltd. | Abuse deterrent immediate release biphasic matrix solid dosage form |
| JP2017518980A (ja) | 2014-05-12 | 2017-07-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | タペンタドールを含む、改変防止即時放出カプセル製剤 |
| US9872835B2 (en) | 2014-05-26 | 2018-01-23 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
| MA40332A (fr) | 2014-07-09 | 2021-04-28 | Rhodes Tech | Réduction des niveaux de cétone alpha, beta-insaturée dans des compositions de dérivés de morphinane |
| CA2910865C (en) | 2014-07-15 | 2016-11-29 | Isa Odidi | Compositions and methods for reducing overdose |
| US20160052932A1 (en) * | 2014-08-25 | 2016-02-25 | Johnson Matthey Public Limited Company | Processes for Making Opioids Including 14-Hydroxycodeinone and 14-hydroxymorphinone |
| US9849124B2 (en) | 2014-10-17 | 2017-12-26 | Purdue Pharma L.P. | Systems and methods for treating an opioid-induced adverse pharmacodynamic response |
| CN105777766B (zh) * | 2014-12-15 | 2017-11-24 | 北大方正集团有限公司 | Delta‑7溴甲纳曲酮的制备方法 |
| US9918979B2 (en) * | 2015-01-29 | 2018-03-20 | Johnson Matthey Public Limited Company | Process of preparing low ABUK oxymorphone hydrochloride |
| BR112017021475A2 (pt) | 2015-04-24 | 2018-07-10 | Gruenenthal Gmbh | forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente |
| GB201513203D0 (en) | 2015-07-27 | 2015-09-09 | Cambrex Charles City Inc | New process |
| WO2017040607A1 (en) | 2015-08-31 | 2017-03-09 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
| US10842750B2 (en) | 2015-09-10 | 2020-11-24 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
| US9943513B1 (en) | 2015-10-07 | 2018-04-17 | Banner Life Sciences Llc | Opioid abuse deterrent dosage forms |
| US10335405B1 (en) | 2016-05-04 | 2019-07-02 | Patheon Softgels, Inc. | Non-burst releasing pharmaceutical composition |
| WO2018055199A1 (en) | 2016-09-26 | 2018-03-29 | Euro-Celtique S.A. | Methods of treatment comprising administering a high daily dose of oxycodone and naloxone in a 2:1 weight ratio |
| US10335375B2 (en) | 2017-05-30 | 2019-07-02 | Patheon Softgels, Inc. | Anti-overingestion abuse deterrent compositions |
| CA3067718A1 (en) * | 2017-06-20 | 2018-12-27 | Johnson Matthey Public Limited Company | Hydrogenation process for preparing oxycodone hydrochloride from 14-hydroxycodeinone |
| KR20200022026A (ko) | 2017-06-30 | 2020-03-02 | 퍼듀 퍼머 엘피 | 치료 방법 및 이의 약형 |
| CN110330500B (zh) * | 2019-07-12 | 2021-11-23 | 宜昌人福药业有限责任公司 | 一种6β-羟基-7,8-二氢-吗啡衍生物的立体选择性合成方法 |
| CN113009060B (zh) * | 2021-02-24 | 2022-10-21 | 西南药业股份有限公司 | 高效液相色谱法测定盐酸羟考酮含量的方法 |
Family Cites Families (97)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE296916C (cg-RX-API-DMAC7.html) * | ||||
| US1468805A (en) | 1923-09-25 | Htabtin ereund | ||
| US105553A (en) | 1870-07-19 | Improvement in kettle for melting, mixing, and casting metals | ||
| US100000A (en) * | 1870-02-22 | Improved sun-bonnet for horses | ||
| US420098A (en) * | 1890-01-28 | Mowing-machine | ||
| US1485673A (en) * | 1924-03-04 | Ministrator | ||
| DE286431C (cg-RX-API-DMAC7.html) | ||||
| US710223A (en) * | 1901-06-10 | 1902-09-30 | Thew Automatic Shovel Company | Power-shovel. |
| SU64699A1 (ru) | 1944-01-26 | 1944-11-30 | А.И. Лютенберг | Способ получени сол нокислого дигидрооксикодеинона |
| ES212554A1 (es) | 1953-12-01 | 1954-08-16 | Casanovas Albajes Cesar | Un procedimiento para la obtención de un vidrio orgánico |
| US2772270A (en) | 1954-10-21 | 1956-11-27 | M J Lewenstein | 14-hydroxymorphinone and 8, 14-dihydroxydihydromorphinone |
| US2806033A (en) | 1955-08-03 | 1957-09-10 | Lewenstein | Morphine derivative |
| US3173878A (en) * | 1960-02-26 | 1965-03-16 | Ibm | Process of making microcapsules |
| US3173876A (en) | 1960-05-27 | 1965-03-16 | John C Zobrist | Cleaning methods and compositions |
| NL271831A (cg-RX-API-DMAC7.html) | 1960-11-29 | |||
| US3276586A (en) | 1963-08-30 | 1966-10-04 | Rosaen Filter Co | Indicating means for fluid filters |
| US3916898A (en) | 1964-05-20 | 1975-11-04 | Searle & Co | Administration of medicaments and the like |
| NL6714885A (cg-RX-API-DMAC7.html) | 1967-11-02 | 1969-05-06 | ||
| US3541006A (en) | 1968-07-03 | 1970-11-17 | Amicon Corp | Ultrafiltration process |
| US3541005A (en) | 1969-02-05 | 1970-11-17 | Amicon Corp | Continuous ultrafiltration of macromolecular solutions |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US3905981A (en) | 1973-10-12 | 1975-09-16 | Research Corp | N-dealkylation of tertiary amines |
| US3894026A (en) | 1973-10-16 | 1975-07-08 | Merck & Co Inc | Production of thebaine |
| GB1478759A (en) | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
| US4077407A (en) | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
| US4063064A (en) | 1976-02-23 | 1977-12-13 | Coherent Radiation | Apparatus for tracking moving workpiece by a laser beam |
| US3984026A (en) * | 1976-03-26 | 1976-10-05 | Shoup Russel W | Combined can opening and sealing device |
| US4045440A (en) | 1976-09-16 | 1977-08-30 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Method of producing thebaine from codeine and oripavine from morphine |
| US4200098A (en) | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
| US4285987A (en) | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
| US4272540A (en) | 1979-04-24 | 1981-06-09 | Sisa, Incorporated | 14-Methoxymorphinan-6-one compounds and therapeutic methods of treating pain and drug dependence with them |
| US4370333A (en) * | 1981-06-29 | 1983-01-25 | Sisa, Incorporated | 17-Cyclopropylmethyl-3-hydroxy-14-methoxy 7α-methyl-morphinan-6-one and therapeutic method of treating pain with it |
| US4795813A (en) | 1981-08-17 | 1989-01-03 | The Florida Board Of Regents On Behalf Of The Florida State University | Synthesis of derivatives of codeine and other 3-O-alkylmorphines |
| US5112975A (en) | 1984-03-27 | 1992-05-12 | Mallinckrodt Specialty Chemicals Company | Preparation of noroxymorphone from morphine |
| US4639520A (en) | 1984-03-27 | 1987-01-27 | Mallinckrodt, Inc. | Preparation of 14-hydroxy-N-ethoxy-carbonyl-norcodeinone |
| US4861598A (en) | 1986-07-18 | 1989-08-29 | Euroceltique, S.A. | Controlled release bases for pharmaceuticals |
| US4810699A (en) | 1987-02-20 | 1989-03-07 | American Home Products Corporation | Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them |
| KR930001499B1 (ko) * | 1987-07-07 | 1993-03-02 | 오끼뎅끼 고오교오 가부시끼가이샤 | 반도체 장치의 제조방법 |
| DE3812567A1 (de) | 1988-04-15 | 1989-10-26 | Basf Ag | Verfahren zur herstellung pharmazeutischer mischungen |
| HU208633B (en) | 1991-02-04 | 1993-12-28 | Alkaloida Vegyeszeti Gyar | Process for production of analgetic compositions as applicable for blocking of opioid-binding spaces /2-receptors/ causing respiration depression |
| US5215758A (en) | 1991-09-11 | 1993-06-01 | Euroceltique, S.A. | Controlled release matrix suppository for pharmaceuticals |
| US5266331A (en) | 1991-11-27 | 1993-11-30 | Euroceltique, S.A. | Controlled release oxycodone compositions |
| US5656295A (en) | 1991-11-27 | 1997-08-12 | Euro-Celtique, S.A. | Controlled release oxycodone compositions |
| US5286493A (en) | 1992-01-27 | 1994-02-15 | Euroceltique, S.A. | Stabilized controlled release formulations having acrylic polymer coating |
| US5472712A (en) | 1991-12-24 | 1995-12-05 | Euroceltique, S.A. | Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
| US5273760A (en) | 1991-12-24 | 1993-12-28 | Euroceltigue, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| US5324351A (en) | 1992-08-13 | 1994-06-28 | Euroceltique | Aqueous dispersions of zein and preparation thereof |
| JP3433871B2 (ja) * | 1996-01-26 | 2003-08-04 | 株式会社デンソー | 集積化半導体歪みセンサ及びその製造方法 |
| WO1997049384A1 (en) | 1996-06-26 | 1997-12-31 | Board Of Regents, The University Of Texas System | Hot-melt extrudable pharmaceutical formulation |
| US5869669A (en) | 1996-07-26 | 1999-02-09 | Penick Corporation | Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates |
| ES2121554B1 (es) * | 1996-12-23 | 1999-06-16 | Univ Santiago Compostela | Procedimiento de obtencion de 14-hidroximofinonas mediante fotooxidac ion de alcaloides morfinicos con sistema alcoxidienico en el anillo c. |
| GB9713703D0 (en) | 1997-06-30 | 1997-09-03 | Johnson Matthey Plc | Preparation of opiates |
| GB9717629D0 (en) | 1997-08-21 | 1997-10-22 | Johnson Matthey Plc | Removal of residual organic solvents |
| US6710223B1 (en) * | 1997-09-10 | 2004-03-23 | The Procter & Gamble Company | Method for improving skin condition |
| GB9805516D0 (en) | 1998-03-17 | 1998-05-13 | Johnson Matthey Plc | Preparation of opiates |
| WO2000021728A1 (en) * | 1998-10-14 | 2000-04-20 | Åmic AB | A matrix and method of producing said matrix |
| US6177567B1 (en) * | 1999-10-15 | 2001-01-23 | Boehringer Ingelheim Chemicals, Inc. | Method for preparing oxycodone |
| US6284769B1 (en) * | 1999-12-03 | 2001-09-04 | The Board Of Trustees Of The University Of Illinois | Nonpeptide kappa opioid receptor antagonists |
| US6133132A (en) * | 2000-01-20 | 2000-10-17 | Advanced Micro Devices, Inc. | Method for controlling transistor spacer width |
| CN101703777B (zh) * | 2000-02-08 | 2012-11-28 | 欧罗赛铁克股份有限公司 | 抗破坏口服阿片样激动剂 |
| EP1285902A4 (en) | 2000-05-29 | 2007-04-18 | Shionogi & Co | TRITIUM MARKING PROCESS |
| US7200357B2 (en) * | 2000-10-20 | 2007-04-03 | Universal Electronics Inc. | Automotive storage and playback device and method for using the same |
| UA81224C2 (uk) | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| KR20040014544A (ko) * | 2001-06-05 | 2004-02-14 | 컨트롤 딜리버리 시스템즈 인코포레이티드 | 서방 진통제 화합물 |
| JP2004534056A (ja) | 2001-06-08 | 2004-11-11 | エンドー ファーマシューティカルズ， インコーポレイティド | アクリルポリマーを使用する制御放出投薬形態、およびそれを作製するためのプロセス |
| MXPA04000584A (es) | 2001-07-18 | 2004-04-20 | Euro Celtique Sa | COMBINACIONES FARMACeUTICAS DE OXICODONA Y NALOXONA. |
| EP1474198B1 (en) * | 2002-01-15 | 2015-12-30 | Novartis AG | System for clearing aerosols from the effective anatomic dead space |
| JP4790219B2 (ja) * | 2002-03-26 | 2011-10-12 | ユーロ−セルティーク エス．エイ． | 徐放性ゲルコーティング組成物 |
| CN1665482A (zh) * | 2002-04-29 | 2005-09-07 | 阿尔扎公司 | 羟可待酮控制输送给药的方法和剂型 |
| CA2455586C (en) * | 2002-05-27 | 2012-01-03 | Ntt Docomo, Inc. | Mobile communication system, transmission station, reception station, relay station, communication path deciding method, and communication path deciding program |
| PL372797A1 (en) | 2002-05-31 | 2005-08-08 | Alza Corporation | Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone |
| WO2004004693A1 (en) * | 2002-07-05 | 2004-01-15 | Collgegium Pharmaceutical | Abuse-deterrent pharmaceutical compositions of opiods and other drugs |
| US20040058946A1 (en) * | 2002-07-05 | 2004-03-25 | Buchwald Stephen L. | Abuse-resistant prodrugs of oxycodone and other pharmaceuticals |
| AU2003258280A1 (en) * | 2002-08-15 | 2004-03-03 | Noramco, Inc. | Oxycodone-hydrochloride polymorhs |
| WO2004045551A2 (en) | 2002-11-15 | 2004-06-03 | Branded Products For The Future | Pharmaceutical composition |
| JP2006515861A (ja) * | 2002-11-29 | 2006-06-08 | フォレスト ラボラトリーズ インコーポレーテッド | イブプロフェンとオキシコドンを含有する単位剤形での急性痛の治療方法 |
| FR2850576B1 (fr) * | 2003-02-05 | 2007-03-23 | Ethypharm Sa | Composition comprenant un melange de principes actifs, et procede de preparation |
| EP1603597B1 (en) | 2003-03-13 | 2010-01-06 | Controlled Chemicals, Inc. | Oxycodone conjugates with lower abuse potential and extended duration of action |
| US6864370B1 (en) | 2003-06-05 | 2005-03-08 | Zhaiwei Lin | Process for manufacturing oxycodone |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| US20070172958A1 (en) * | 2004-03-30 | 2007-07-26 | Euro-Celtique S.A. | Methods for detecting 14-hydroxy codeinone and codeinone |
| TW201509943A (zh) * | 2004-03-30 | 2015-03-16 | Euro Celtique Sa | 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝 |
| US20050226929A1 (en) | 2004-04-12 | 2005-10-13 | Jianbo Xie | Controlled release opioid analgesic formulation |
| JP5329083B2 (ja) | 2004-06-25 | 2013-10-30 | テッセラ，インコーポレイテッド | ポストおよびパッドを有する部品 |
| GB0421149D0 (en) | 2004-09-23 | 2004-10-27 | Johnson Matthey Plc | Preparation of oxycodone |
| DE602006018208D1 (de) | 2005-03-04 | 2010-12-23 | Euro Celtique Sa | Verfahren zur Verminderung von Alpha, Beta-ungesättigten Ketonen in Opioidzusammensetzungen |
| ES2357216T3 (es) | 2005-06-16 | 2011-04-20 | Mallinckrodt, Inc. | Una ruta de síntesis de 14-hidroxil-opiáceos a través de 1-halo-tebaína o análogos. |
| JP5415075B2 (ja) | 2005-11-22 | 2014-02-12 | コントロールド・ケミカルズ・インコーポレーテッド | オキシコドン及び他の組成物中の混入しているマイケル受容体レベルを低減させる方法 |
| US20070117826A1 (en) | 2005-11-23 | 2007-05-24 | Forest Laboratories, Inc. | Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone |
| ATE448231T1 (de) | 2006-03-02 | 2009-11-15 | Mallinckrodt Inc | Verfahren zur herstellung von morphinan-6-on- produkten mit geringen konzentrationen von alpha-,beta-ungesättigten ketonverbindungen |
| SA07280459B1 (ar) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
| US7875719B2 (en) * | 2006-12-04 | 2011-01-25 | Cox D Phillip | Process for reducing impurities in oxycodone base |
| JP2010511726A (ja) * | 2006-12-04 | 2010-04-15 | ノランコ・インコーポレーテツド | １４−ヒドロキシコデイノンの濃度が低いオキシコドンの製造方法 |
| GB2450691A (en) | 2007-07-02 | 2009-01-07 | Alpharma Aps | One-pot preparation of oxycodone from thebaine |
| GB2495062A (en) | 2010-07-02 | 2013-03-27 | Johnson Matthey Plc | Process for the synthesis and purification of oxycodone |
| US9062062B1 (en) * | 2013-12-18 | 2015-06-23 | Cody Laboratories, Inc. | Synthesis of oxycodone hydrochloride |
-
2005
- 2005-03-15 TW TW103140205A patent/TW201509943A/zh unknown
- 2005-03-15 TW TW094107824A patent/TWI365880B/zh not_active IP Right Cessation
- 2005-03-15 TW TW101106699A patent/TWI483944B/zh not_active IP Right Cessation
- 2005-03-23 MY MYPI20051252A patent/MY143205A/en unknown
- 2005-03-23 MY MYPI2011004160A patent/MY172063A/en unknown
- 2005-03-23 MY MYPI20090495A patent/MY154985A/en unknown
- 2005-03-29 PE PE2005000361A patent/PE20050880A1/es active IP Right Grant
- 2005-03-30 RS RS20160561A patent/RS54941B1/sr unknown
- 2005-03-30 PT PT05730345T patent/PT1730151E/pt unknown
- 2005-03-30 EA EA200601520A patent/EA013208B1/ru not_active IP Right Cessation
- 2005-03-30 RS RS20160189A patent/RS54598B1/sr unknown
- 2005-03-30 EP EP11186168.8A patent/EP2426132B1/en not_active Expired - Lifetime
- 2005-03-30 ME MEP-2018-71A patent/ME03068B/me unknown
- 2005-03-30 DK DK11186168.8T patent/DK2426132T3/en active
- 2005-03-30 KR KR1020097019843A patent/KR100993911B1/ko not_active Expired - Lifetime
- 2005-03-30 EP EP10011791A patent/EP2311839A1/en not_active Withdrawn
- 2005-03-30 DK DK10011792T patent/DK2305683T3/en active
- 2005-03-30 HU HUE10011788A patent/HUE036451T2/hu unknown
- 2005-03-30 PL PL10011788T patent/PL2316837T3/pl unknown
- 2005-03-30 EP EP10011788.6A patent/EP2316837B1/en not_active Expired - Lifetime
- 2005-03-30 KR KR1020127006697A patent/KR20120046309A/ko not_active Ceased
- 2005-03-30 NZ NZ601326A patent/NZ601326A/xx not_active IP Right Cessation
- 2005-03-30 HU HUE10011787A patent/HUE029913T2/en unknown
- 2005-03-30 KR KR1020127017379A patent/KR20120106784A/ko not_active Ceased
- 2005-03-30 CA CA2557845A patent/CA2557845C/en not_active Expired - Lifetime
- 2005-03-30 CA CA2913355A patent/CA2913355C/en not_active Expired - Lifetime
- 2005-03-30 DE DE602005026786T patent/DE602005026786D1/de not_active Expired - Lifetime
- 2005-03-30 NZ NZ549430A patent/NZ549430A/en not_active IP Right Cessation
- 2005-03-30 KR KR1020147001423A patent/KR20140021716A/ko not_active Withdrawn
- 2005-03-30 DK DK05730345.5T patent/DK1730151T4/da active
- 2005-03-30 SI SI200532083A patent/SI2319846T1/sl unknown
- 2005-03-30 CN CN2005800106471A patent/CN1960994B/zh not_active Expired - Lifetime
- 2005-03-30 PL PL10011787.8T patent/PL2319846T3/pl unknown
- 2005-03-30 HU HUE11186168A patent/HUE028233T2/en unknown
- 2005-03-30 AP AP2006003738A patent/AP2232A/xx active
- 2005-03-30 KR KR1020147030767A patent/KR20140133615A/ko not_active Ceased
- 2005-03-30 SG SG10201406658VA patent/SG10201406658VA/en unknown
- 2005-03-30 PT PT100117928T patent/PT2305683E/pt unknown
- 2005-03-30 PT PT100117886T patent/PT2316837T/pt unknown
- 2005-03-30 JP JP2007506507A patent/JP4912294B2/ja not_active Expired - Lifetime
- 2005-03-30 KR KR1020197038467A patent/KR20200000499A/ko not_active Ceased
- 2005-03-30 ES ES10011788.6T patent/ES2665287T3/es not_active Expired - Lifetime
- 2005-03-30 ME MEP-2016-58A patent/ME02411B/me unknown
- 2005-03-30 SG SG201101934-6A patent/SG170736A1/en unknown
- 2005-03-30 KR KR1020107013435A patent/KR20100069719A/ko not_active Ceased
- 2005-03-30 CN CN2010106226501A patent/CN102127086B/zh not_active Expired - Lifetime
- 2005-03-30 KR KR1020157009780A patent/KR20150046393A/ko not_active Ceased
- 2005-03-30 SI SI200532200T patent/SI2316837T1/en unknown
- 2005-03-30 PT PT100117878T patent/PT2319846T/pt unknown
- 2005-03-30 KR KR1020137000989A patent/KR101410141B1/ko not_active Expired - Lifetime
- 2005-03-30 DE DE202005021371U patent/DE202005021371U1/de not_active Expired - Lifetime
- 2005-03-30 AR ARP050101243A patent/AR049012A1/es active IP Right Grant
- 2005-03-30 DK DK10011788.6T patent/DK2316837T3/en active
- 2005-03-30 PL PL05730345.5T patent/PL1730151T5/pl unknown
- 2005-03-30 SI SI200531950T patent/SI2305683T1/sl unknown
- 2005-03-30 CN CN2010101515524A patent/CN101812065B/zh not_active Ceased
- 2005-03-30 CA CA2774121A patent/CA2774121C/en not_active Expired - Lifetime
- 2005-03-30 EP EP10011787.8A patent/EP2319846B1/en not_active Expired - Lifetime
- 2005-03-30 KR KR1020117022725A patent/KR101200700B1/ko not_active Expired - Lifetime
- 2005-03-30 PT PT111861688T patent/PT2426132E/pt unknown
- 2005-03-30 ES ES11186168.8T patent/ES2566363T3/es not_active Expired - Lifetime
- 2005-03-30 LT LTEP10011793.6T patent/LT2314589T/lt unknown
- 2005-03-30 NZ NZ602862A patent/NZ602862A/en not_active IP Right Cessation
- 2005-03-30 AU AU2005230826A patent/AU2005230826C1/en not_active Expired
- 2005-03-30 ES ES10011793T patent/ES2938727T3/es not_active Expired - Lifetime
- 2005-03-30 CN CN201210257643.5A patent/CN102838607B/zh not_active Expired - Lifetime
- 2005-03-30 EP EP05730345.5A patent/EP1730151B2/en not_active Expired - Lifetime
- 2005-03-30 SI SI200531289T patent/SI1730151T2/sl unknown
- 2005-03-30 AT AT05730345T patent/ATE501150T1/de active
- 2005-03-30 LT LTEP10011788.6T patent/LT2316837T/lt unknown
- 2005-03-30 KR KR1020067022569A patent/KR100930730B1/ko not_active Expired - Lifetime
- 2005-03-30 ME MEP-2011-91A patent/ME01299B/me unknown
- 2005-03-30 PL PL10011792T patent/PL2305683T3/pl unknown
- 2005-03-30 HR HRP20110425TT patent/HRP20110425T4/hr unknown
- 2005-03-30 ME MEP-2016-148A patent/ME02482B/me unknown
- 2005-03-30 SG SG201101931-2A patent/SG170735A1/en unknown
- 2005-03-30 PL PL11186168T patent/PL2426132T3/pl unknown
- 2005-03-30 RS RS20150215A patent/RS53891B1/sr unknown
- 2005-03-30 ES ES05730345T patent/ES2362282T5/es not_active Expired - Lifetime
- 2005-03-30 EP EP10011793.6A patent/EP2314589B1/en not_active Expired - Lifetime
- 2005-03-30 EP EP10011792.8A patent/EP2305683B2/en not_active Expired - Lifetime
- 2005-03-30 ES ES10011787.8T patent/ES2585576T3/es not_active Expired - Lifetime
- 2005-03-30 WO PCT/US2005/010666 patent/WO2005097801A1/en not_active Ceased
- 2005-03-30 CN CN201210256799.1A patent/CN102887903B/zh not_active Expired - Lifetime
- 2005-03-30 RS RS20110209A patent/RS51693B2/sr unknown
- 2005-03-30 US US11/093,626 patent/US7129248B2/en not_active Expired - Lifetime
- 2005-03-30 ES ES10011792.8T patent/ES2535618T3/es not_active Expired - Lifetime
- 2005-03-30 DK DK10011787.8T patent/DK2319846T3/en active
- 2005-03-30 MX MX2013004023A patent/MX363228B/es unknown
- 2005-03-30 SI SI200532046T patent/SI2426132T1/sl unknown
- 2005-03-30 BR BRPI0508758A patent/BRPI0508758B8/pt active IP Right Grant
- 2005-03-30 KR KR1020187021551A patent/KR20180088505A/ko not_active Ceased
- 2005-03-30 RS RS20180297A patent/RS57000B1/sr unknown
-
2006
- 2006-03-29 US US11/391,897 patent/US20060173029A1/en not_active Abandoned
- 2006-08-29 ZA ZA200607181A patent/ZA200607181B/en unknown
- 2006-09-04 CR CR8593A patent/CR8593A/es unknown
- 2006-09-08 MX MX2020008878A patent/MX2020008878A/es unknown
- 2006-09-12 IL IL178038A patent/IL178038A/en active IP Right Grant
- 2006-09-28 MA MA29351A patent/MA28492B1/fr unknown
- 2006-10-26 EC EC2006006953A patent/ECSP066953A/es unknown
- 2006-10-27 NO NO20064935A patent/NO337669B1/no unknown
-
2007
- 2007-01-16 US US11/653,529 patent/US7683072B2/en not_active Expired - Lifetime
- 2007-01-16 US US11/653,531 patent/US7674799B2/en not_active Expired - Lifetime
- 2007-01-16 US US11/653,530 patent/US7674798B2/en not_active Expired - Lifetime
- 2007-03-29 US US11/729,741 patent/US7674800B2/en not_active Expired - Lifetime
- 2007-07-04 FI FI20070284U patent/FI7843U1/fi not_active IP Right Cessation
- 2007-08-02 DK DK200700214U patent/DK200700214U3/da not_active IP Right Cessation
- 2007-09-03 AT AT0052507U patent/AT9952U1/de not_active IP Right Cessation
-
2009
- 2009-01-30 AU AU2009200335A patent/AU2009200335B2/en not_active Expired
- 2009-03-04 US US12/380,800 patent/US20090227615A1/en not_active Abandoned
-
2010
- 2010-02-24 US US12/711,948 patent/US8822687B2/en not_active Expired - Lifetime
- 2010-09-29 US US12/893,681 patent/US20110207762A1/en not_active Abandoned
-
2011
- 2011-03-17 JP JP2011058728A patent/JP5118223B2/ja not_active Expired - Lifetime
- 2011-05-23 CY CY20111100503T patent/CY1111487T1/el unknown
- 2011-06-30 IL IL213888A patent/IL213888A0/en active IP Right Grant
- 2011-06-30 CR CR20110376A patent/CR20110376A/es unknown
- 2011-06-30 IL IL213891A patent/IL213891A0/en active IP Right Grant
- 2011-06-30 IL IL213889A patent/IL213889A/en active IP Right Grant
- 2011-06-30 IL IL213890A patent/IL213890A/en active IP Right Grant
- 2011-07-12 IL IL214050A patent/IL214050A/en active IP Right Grant
- 2011-11-17 JP JP2011251260A patent/JP5378486B2/ja not_active Expired - Lifetime
-
2012
- 2012-02-06 US US13/366,755 patent/US9073933B2/en active Active
- 2012-05-30 JP JP2012123160A patent/JP5543991B2/ja not_active Expired - Lifetime
-
2014
- 2014-03-07 JP JP2014045713A patent/JP2014139205A/ja active Pending
- 2014-10-23 IL IL235298A patent/IL235298A/en active IP Right Grant
-
2015
- 2015-03-30 HR HRP20150358TT patent/HRP20150358T1/hr unknown
- 2015-04-17 CY CY20151100357T patent/CY1116327T1/el unknown
- 2015-05-28 JP JP2015108759A patent/JP2015187134A/ja active Pending
- 2015-05-29 US US14/725,110 patent/US20150258086A1/en not_active Abandoned
- 2015-05-29 US US14/725,210 patent/US20150265598A1/en not_active Abandoned
- 2015-05-29 US US14/725,153 patent/US9522919B2/en not_active Expired - Lifetime
- 2015-09-03 IL IL241117A patent/IL241117B/en active IP Right Grant
-
2016
- 2016-03-01 HR HRP20160223T patent/HRP20160223T1/hr unknown
- 2016-03-02 US US15/058,812 patent/US20160250205A1/en not_active Abandoned
- 2016-03-02 US US15/058,912 patent/US20160176889A1/en not_active Abandoned
- 2016-03-02 US US15/058,390 patent/US20160176888A1/en not_active Abandoned
- 2016-03-02 US US15/058,379 patent/US20160175299A1/en not_active Abandoned
- 2016-03-02 US US15/058,420 patent/US9777011B2/en not_active Expired - Fee Related
- 2016-03-02 US US15/058,960 patent/US20160175300A1/en not_active Abandoned
- 2016-03-02 US US15/058,363 patent/US20160175298A1/en not_active Abandoned
- 2016-03-04 US US15/061,681 patent/US20160185790A1/en not_active Abandoned
- 2016-03-04 US US15/061,477 patent/US20160185788A1/en not_active Abandoned
- 2016-03-04 US US15/061,733 patent/US20160251365A1/en not_active Abandoned
- 2016-03-04 US US15/061,640 patent/US20160264588A1/en not_active Abandoned
- 2016-03-04 US US15/061,588 patent/US20160251364A1/en not_active Abandoned
- 2016-03-04 US US15/061,541 patent/US20160185789A1/en not_active Abandoned
- 2016-03-04 US US15/061,416 patent/US20160251363A1/en not_active Abandoned
- 2016-03-04 CY CY20161100188T patent/CY1117228T1/el unknown
- 2016-07-15 HR HRP20160885TT patent/HRP20160885T1/hr unknown
- 2016-07-20 CY CY20161100711T patent/CY1117841T1/el unknown
-
2017
- 2017-03-08 JP JP2017043530A patent/JP6503392B2/ja not_active Expired - Lifetime
- 2017-09-29 US US15/721,167 patent/US10259819B2/en not_active Expired - Lifetime
-
2018
- 2018-03-08 HR HRP20180407TT patent/HRP20180407T1/hr unknown
- 2018-03-12 CY CY20181100298T patent/CY1120171T1/el unknown
- 2018-07-31 JP JP2018144003A patent/JP2018184462A/ja active Pending
-
2019
- 2019-01-30 US US16/262,683 patent/US10407434B2/en not_active Expired - Lifetime
- 2019-08-30 US US16/557,937 patent/US10689389B2/en not_active Expired - Lifetime
- 2019-11-20 US US16/690,052 patent/US10696684B2/en not_active Expired - Lifetime
-
2020
- 2020-06-12 US US16/900,600 patent/US11384091B2/en not_active Expired - Lifetime
-
2021
- 2021-03-15 US US17/202,320 patent/US11236098B2/en not_active Expired - Lifetime
-
2022
- 2022-07-11 US US17/811,736 patent/US20230159548A1/en not_active Abandoned
-
2023
- 2023-06-07 US US18/330,932 patent/US12060361B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20050880A1 (es) | Proceso para reducir la cantidad de 14-hidroxicodeinona en una preparacion de clorhidrato de oxicodona | |
| TW200643225A (en) | Regeneration of cupric etchants and recovery of copper sulfate | |
| EP1193244A3 (en) | Method for producing xylylenediamine | |
| TW200710081A (en) | Process for producing carboxylic acid | |
| EP1894887A3 (de) | Verfahren zur Aufarbeitung einer Ätzmischung, die bei der Herstellung von hochreinem Silizium anfällt | |
| CO6670555A2 (es) | Método para recuperar oro por extracción con solvente | |
| BRPI0401876A (pt) | Processo para recuperação de catalisador de metal de um licor mãe, corrente de impurezas orgânicas com alto ponto de ebulição, corrente rica em solvente, processo para produção de uma corrente de licor mãe superconcentrado, e, composição | |
| MY170077A (en) | Lactic acid extraction | |
| JP2006291352A5 (cg-RX-API-DMAC7.html) | ||
| RU2012137266A (ru) | Способ получения водного потока при получении эталона | |
| AR044238A1 (es) | Composicion y proceso de extraccion de metal | |
| RU2010133160A (ru) | Способ синтеза тетрагидробиоптерина | |
| BR112012028507A2 (pt) | processo para recuperação de etanol com extrações laterais para regular as concentrações de c3 + alcoóis | |
| GB2437006A (en) | Salts assisted selective extraction of 6-acetyl-4.1',6'trichlorogalactosucrose and 4,1',6'trichlorogalactosucrose from aqueous reaction mixture | |
| DE602005000334D1 (de) | Verfahren zur herstellung von oxycodon | |
| JOP20210055A1 (ar) | عملية لتنقية وتركيز العناصر الأرضية النادرة من الجبس الفوسفوري | |
| ATE338016T1 (de) | Verfahren zur reinigung von hexafluor-1,3- butadien | |
| PE20050001A1 (es) | Metodo y equipo para purificar una solucion de extraccion de un arrastre acuoso e impurezas | |
| JP4552941B2 (ja) | アニリンの精製方法および製造方法 | |
| ECSP099543A (es) | Método y aparato para recuperar un metal y separar el arsénico de una solución que contiene arsénico | |
| ES2189764T3 (es) | Proceso para la separacion y purificacion de una mezcla acuosa que tiene como componentes principales acido acetico y acido formico. | |
| BRPI0411925A (pt) | processo para separação e recuperação de ácido 3-hidroxipropiÈnico e ácido acrìlico | |
| RU2005109425A (ru) | Способ экстракции растворителем | |
| CN1123825A (zh) | 一种石油馏分油氨醇脱酸工艺 | |
| MX2021007012A (es) | Recuperación de valores de oro y plata de alimentos mediante extracción asistida por ultrasonido. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |